•  
  •  
  •  
  •  

2026-07-22 07:20:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  PPLPHARMA

Stock Report

  • Piramal Pharma Solutions and NewAmsterdam Pharma announce dedicated OSD production Capabilities at Piramal's Sellersville, Pennsylvania Site
  • Piramal Pharma Ltd completes USFDA inspection of Aurora facility with Zero Form-483 observations
  • Piramal Pharma Limited recommends final dividend of Rs. 0.14
  • BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
  • US FDA Inspection at Piramal Pharma's facility located at Turbhe
  • Piramal Critical Care announces U.S. Launch of Chlorpromazine Hydrochloride for Injection, USP
  • Piramal Pharma Solutions announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
  • Piramal Pharma's GHG Commitment Validated and Approved by SBTi
  • Piramal Pharma Limited's Ahmedabad facility successfully completes USFDA Pre-Approval Inspection
  • Piramal Pharma Ltd recommends final dividend of Rs. 0.11
  • Piramal Pharma Limited Launches New Campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta
  • Piramal Pharma Ltd forays into men's grooming market in India with the launch of BOHEM
  • Piramal Pharma Ltd gets Form 483 with 2 observations from USFDA for Lexington, USA facility
  • Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
  • USFDA inspection at Piramal Pharma Ltd's Bethlehem facility
  • Piramal Pharma Limited fixes Aug 2, 2023 as record date for rights issue
  • Piramal Critical Care appoints Jeffrey Hampton as President & Chief Operating Officer
  • Piramal Pharma gets EIR from USFDA for Sellersville, USA facility
  • Piramal Pharma Limited gets EIR for Lexington, Kentucky facility
  • Piramal Pharma Ltd reports Rs. 90.18 crores consolidated loss in Q3 FY2023
  • Piramal Pharma Ltd gets 2 observations from USFDA for Sellersville facility
  • Piramal Pharma Ltd gets 6 observations from USFDA for Lexington facility
  • Piramal Pharma Ltd gets zero observations from USFDA for Riverview, Michigan facility
  • Piramal Phamra Ltd reports consolidated loss of Rs. 37.34 crores in Q2 FY2023

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025